Canada markets closed

BioVaxys Technology Corp. (BVAXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1238-0.0262 (-17.49%)
At close: 03:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.52M
Enterprise Value 8.50M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.03
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.50

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-54.55%
S&P500 52-Week Change 3-14.01%
52 Week High 30.3800
52 Week Low 30.0616
50-Day Moving Average 30.0929
200-Day Moving Average 30.1131

Share Statistics

Avg Vol (3 month) 351.83k
Avg Vol (10 day) 342.32k
Shares Outstanding 597.95M
Implied Shares Outstanding 6N/A
Float 880.26M
% Held by Insiders 118.94%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Apr 27, 2020

Financial Highlights

Currency in CAD.

Fiscal Year

Fiscal Year Ends Oct 30, 2021
Most Recent Quarter (mrq)Jul 30, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.79%
Return on Equity (ttm)-73.23%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-5.7M
Diluted EPS (ttm)-0.0540
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)39.05k
Total Cash Per Share (mrq)0
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.16
Book Value Per Share (mrq)0.06

Cash Flow Statement

Operating Cash Flow (ttm)-2.13M
Levered Free Cash Flow (ttm)147.88k